Form 4 for CNMD CONMED Corp
Accepted 2021-08-31 00:00:00 ET · period of report 2021-08-30 · accession 0001127602-21-024594 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-31 | 2021-08-30 | CNMD | KENNEDY JOHN JED | Group EVP | M - OptEx | $46.70 | +4,240 | 7,575 | +127% | +$198.0K |
| DM | 2021-08-31 | 2021-08-30 | CNMD | KENNEDY JOHN JED | Group EVP | S - Sale+OE | $134.75 | -4,240 | 7,375 | -37% | -$571.3K |
| DM | 2021-08-31 | 2021-08-30 | CNMD | KENNEDY JOHN JED | Group EVP | M - OptEx | $0.00 | -4,240 | 5,862 | -42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-30 | M | A | 300 | $59.96 | 7,675 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-30 | S | D | 300 | $134.75 | 7,375 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-30 | S | D | 3,640 | $134.75 | 7,375 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.75 to $134.79. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 4 | Common | Common Stock | 2021-08-30 | M | A | 3,640 | $41.93 | 11,015 | D | — | — | |
| 5 | Common | Common Stock | 2021-08-30 | S | D | 200 | $134.75 | 7,375 | D | — | — | |
| 6 | Common | Common Stock | 2021-08-30 | M | A | 100 | $78.76 | 7,475 | D | — | — | |
| 7 | Common | Common Stock | 2021-08-30 | S | D | 100 | $134.75 | 7,375 | D | — | — | |
| 8 | Common | Common Stock | 2021-08-30 | M | A | 200 | $97.69 | 7,575 | D | — | — | |
| 9 | Derivative | Options To Purchase Common Stock | 2021-08-30 | M | D | 300 | $0.00 | 15,900 | D | $59.96 · — to 2028-03-01 | 300 Common Stock | (F2) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| 10 | Derivative | Options To Purchase Common Stock | 2021-08-30 | M | D | 200 | $0.00 | 9,300 | D | $97.69 · — to 2030-03-02 | 200 Common Stock | (F3) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 11 | Derivative | Options To Purchase Common Stock | 2021-08-30 | M | D | 100 | $0.00 | 7,500 | D | $78.76 · — to 2029-03-01 | 100 Common Stock | (F3) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 12 | Derivative | Options To Purchase Common Stock | 2021-08-30 | M | D | 3,640 | $0.00 | 5,862 | D | $41.93 · — to 2027-03-01 | 3,640 Common Stock | (F2) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |